Visit Us @
Synergy Centre TU Dublin, Tallaght, D24A386
Mail Us @
info@codlad.com
Call Us @
+353 851890752

Archive for February 5, 2021

FDA Approves New Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma

February 5, 2021

FDA Approves New Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma

Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large B-cell…

FDA Approves New Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma FDA
FDA Authorizes Marketing of Novel Device to Reduce Snoring and Mild Obstructive Sleep Apnea in Patients 18 Years and Older

February 5, 2021

FDA Authorizes Marketing of Novel Device to Reduce Snoring and Mild Obstructive Sleep Apnea in Patients 18 Years and Older

Today, the U.S. Food and Drug Administration authorized marketing of a new prescription only device intended to reduce snoring and mild obstructive sleep apnea. Unlike…

FDA Authorizes Marketing of Novel Device to Reduce Snoring and Mild Obstructive Sleep Apnea in Patients 18 Years and Older FDA
Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.’s COVID-19 Vaccine Candidate

February 5, 2021

Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.’s COVID-19 Vaccine Candidate

The U.S. Food and Drug Administration has scheduled a meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Feb. 26, 2021, to…

Coronavirus (COVID-19) Update: FDA Announces Advisory Committee Meeting to Discuss Janssen Biotech Inc.’s COVID-19 Vaccine Candidate FDA

Latest Posts

FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury
FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury
November 14, 2025
HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
November 10, 2025
HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
HHS Advances Women’s Health, Removes Misleading FDA Warnings on Hormone Replacement Therapy
November 10, 2025